Le Lézard
Classified in: Health
Subjects: SVY, AVO

Ontarians Don't Understand Schizophrenia and People Living With It

WHITBY, ON, Oct. 7, 2019 /CNW/ - A majority of Ontarians are uncomfortable and unfamiliar with the symptoms of schizophrenia, according to a new Ipsos poll conducted on behalf of Ontario Shores Centre for Mental Health Sciences (Ontario Shores).

Schizophrenia touched the life of Candice McAlister when her brother was first diagnosed 15 years ago. The Bowmanville, Ont. resident believes people should have compassion and respect for those living with the chronic illness. (CNW Group/Ontario Shores Centre for Mental Health Sciences)

In honour of its 100th anniversary, the Whitby-based specialty mental health hospital sought the opportunity to gauge society's view of this chronic brain disease, which, according to the Schizophrenia Society of Canada, affects 300,000 Canadians.

The poll revealed that 57 per cent of Ontarians believe people with schizophrenia have multiple personalities, a symptom not associated with the chronic illness.

"It's hurtful how little people know about schizophrenia," notes Candice McAlister, a Bowmanville, Ont. resident whose brother has lived with the disease for more than 15 years. "At the time, it was a popular belief that only those people who had a bad childhood, or experienced abuse or trauma would develop a mental illness, especially one like schizophrenia. This was not the case for my brother, but it made me feel more isolated because I didn't want others to think that about my brother or family."

As McAlister notes, the stigma associated with schizophrenia remains prevalent even as society's literacy around mental health improves thanks to social awareness campaigns and corporate fundraising efforts. However, when it comes to schizophrenia, 61 per cent of Ontarians admit they wouldn't date and 55 per cent say they wouldn't know how to act around someone with schizophrenia.

"This confirms what we already knew," notes Karim Mamdani, President and CEO of Ontario Shores. "People living with schizophrenia are misunderstood, isolated and ignored."

In addition to 90,000 outpatient visits annually, Ontario Shores provides inpatient treatment to adolescent, adult, geriatric and forensic mental health populations. Of its 346 inpatients, more than 55 per cent of patients have a diagnosis of schizophrenia at time of discharge.

"If schizophrenia was a chronic physical illness, people living with it would be treated with compassion, understanding and respect," notes Mamdani. "With treatment, people living with schizophrenia can lead a meaningful life. As a society we need to be caring, empathetic and encouraging of treatment and support."

Mamdani's views of how far we need to go in terms understanding this chronic illness are supported by the data compiled by Ipsos. The poll indicates one in three (34 per cent) wouldn't be willing to hire anyone with schizophrenia while 38 per cent said they wouldn't rent an apartment or room to someone with the disorder. Moreover, a full one in ten (10 per cent) agreed with the idea that people with schizophrenia should be kept away from society, completely.

"Today, my brother has completed his high school credits, has a car, drives, works part time, and he's happy," says McAlister. "He's come a long way compared to those darkest times. It's important that people start to understand, empathize and encourage, and it's critical to know that things can get better."

For information on schizophrenia and its impact on families and clinicians visit www.mindvine.ontarioshores.ca.

About Ontario Shores Centre for Mental Health Sciences:
Ontario Shores Centre for Mental Health Sciences (Ontario Shores) is a leader in mental health care, providing a range of specialized assessment and treatment services for people living with complex mental illness. Patients benefit from a recovery-oriented environment of care, built on compassion, inspiration and hope. Ontario Shores engages in research, education and advocacy initiatives to advance the mental health care system.

About the Study
These are some of the findings of an Ipsos poll conducted between August 13th and 14th, 2019, on behalf of Ontario Shores Centre for Mental Health Sciences. For this survey, a sample of 800 Ontarians were interviewed. Weighting was then employed to balance demographics to ensure that the sample's composition reflects that of the Ontario population according to Census data and to provide results intended to approximate the sample universe. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll is accurate to within ±4.0 percentage points, 19 times out of 20, had all Ontarians been polled. The credibility interval will be wider among subsets of the population. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error, and measurement error.

For more information on this Factum, please contact:
Sean Simpson
Vice President, Ipsos Public Affairs

About Ipsos
Ipsos is the world's third largest market research company, present in 90 markets and employing more than 18,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions.

Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD).

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

Ontario Shores Centre for Mental Health Sciences (CNW Group/Ontario Shores Centre for Mental Health Sciences)

SOURCE Ontario Shores Centre for Mental Health Sciences

These press releases may also interest you

at 09:05
Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced that it had completed software changes and documentation required by the Chinese FDA for...

at 09:05
Octapharma USA and BioMatrix Specialty Pharmacy are supporting a new investigator-initiated research study led by Kelly McCants, M.D., Medical Director of the Norton Heart & Vascular Institute in Louisville, Ky., focused on treating patients with the...

at 09:04
New brand CarryOntm has launched sparkling CBD waters as well as a brand mission to normalize the pursuit of mental wellbeing.  With over 56% of Americans reporting negative effects on their mental wellbeing, CarryOntm believes that the pursuit of...

at 09:00
InspectIR Systems, LLC, a purpose-driven company with proprietary measurement methods, devices and tools, has begun clinical trials aimed at detecting the novel coronavirus (COVID-19). InspectIR partnered with University of North Texas Associate...

at 09:00
CAN Community Health announced that Tampa Family Pharmacy founders Haley Miller and Crystal Campbell have resigned effective immediately and sold their remaining interest to CAN Community Health to spend more time with their respective families....

at 09:00
PTC Therapeutics, Inc. today announced that it will hold a series of virtual deep dive webinars discussing its therapeutic platforms and programs. The first webinar in the series will discuss its Bio-e platform on Friday, June 5 at 10:00 a.m. ET....

News published on 7 october 2019 at 08:00 and distributed by: